+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Concurrent ganciclovir and foscarnet treatment for cytomegalovirus encephalitis and retinitis in an infant with acquired immunodeficiency syndrome: case report and review



Concurrent ganciclovir and foscarnet treatment for cytomegalovirus encephalitis and retinitis in an infant with acquired immunodeficiency syndrome: case report and review



Pediatric Infectious Disease Journal 16(8): 807-811




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 030673689

Download citation: RISBibTeXText

PMID: 9271045


Related references

Combined treatment with ganciclovir and foscarnet for cytomegalovirus retinitis in a patient with acquired immunodeficiency syndrome. Rinsho Ganka 52(5): 803-806, 1998

Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet. Pharmacy World and Science 15(2): 56-67, 1993

Combination ganciclovir and foscarnet in the treatment of clinically resistant cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Archives of Ophthalmology 111(10): 1359-1366, 1993

Combined and alternating ganciclovir and foscarnet in acute and maintenance therapy of human immunodeficiency virus-related cytomegalovirus encephalitis refractory to ganciclovir alone. A case report and review of the literature. Clinical Investigator 70(5): 456-458, 1992

The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: The Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. American Journal of Ophthalmology 131(4): 457-467, 2001

Intravitreal antiviral drug concentration after intravenous ganciclovir and foscarnet in acquired immunodeficiency syndrome patients with cytomegalovirus retinitis. Investigative Ophthalmology & Visual Science 35(4): 1892, 1994

Therapy with a combination of intravitreal foscarnet and intravenous ganciclovir in clinically resistant cytomegalovirus retinitis and patients with acquired immunodeficiency syndrome. German Journal of Ophthalmology 5(6): 490-491, 1996

2.5 years survival with sequential ganciclovir/foscarnet treatment in a patient with acquired immune deficiency syndrome and cytomegalovirus retinitis. German Journal of Ophthalmology 1(2): 110-113, 1992

Combined treatment with zidovudine, lamivudine, nelfinavir and ganciclovir in an infant with human immunodeficiency virus type 1 infection and cytomegalovirus encephalitis: case report and review of the literature. Pediatric Infectious Disease Journal 18(4): 382-386, 1999

Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. Antimicrobial Agents and ChemoTherapy 33(5): 736-741, 1989

Foscarnet treatment of cytomegalovirus gastrointestinal infections in acquired immunodeficiency syndrome patients who have failed ganciclovir induction. American Journal of Gastroenterology 88(4): 542-548, 1993

Ganciclovir and foscarnet dual-therapy for cytomegalovirus encephalitis: A case report and review of the literature. Journal of the Neurological Sciences 388: 28-36, 2018

Treatment of cytomegalovirus retinitis in acquired immunodeficiency syndrome with intravitreal ganciclovir implant. Journal of the Medical Association of Thailand 84(Suppl. 1): S142-S147, 2001

A randomized controlled clinical trial of foscarnet for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 243, 1989

Pharmacokinetics of intermittently administered intravenous foscarnet in the treatment of acquired immunodeficiency syndrome patients with serious cytomegalovirus retinitis. Antimicrobial Agents and ChemoTherapy 33(5): 742-745, 1989